To further confirm the aforementioned finding, the expression of LINC00173, PROCA1, ZFP36L2, and BCL2 was subsequently assessed in the xenograft tumor tissues of control and LINC00173-deleted group with DDP or N.S treatment. This evidence concerns the gene PROCA1 and neoplasm.